Company Info
| Industry | Medical Specialties |
|---|---|
| Sector | Health Technology |
| Employees | 938 |
| CEO | Mr. Nabil Shabshab |
| Address | 301 Coromar Drive , Goleta, CA 93117 |
|---|---|
| Phone | 1.805.562.0500 |
| Website | www.inogen.com |
Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
Statement Summary
as of 4:00 ET PM 01/13/2022| Total Assets (MRQ) | 512.9 M |
|---|---|
| Total Liabilities (MRQ) | 121.9 M |
| Shareholders’ Equity (MRQ) | 390.9 M |
| Total Revenue (Annual) | 93.1 M |
| Net Income (Annual) | 12.2 M |
Earnings And Estimates
as of 4:00 ET PM 01/13/2022
| Current Qtr EPS Estimate | -0.75 |
|---|---|
| Current FY EPS Estimate | -0.03 |
| Long Term EPS Growth Estimate | -19.00 |
| Next Expected Earnings Date | 3/1/2022 |
INGN vs S&P 500
as of 01/13/2022| Relative To S&P 500 |
INGN | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:00 ET PM 01/13/2022| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/2021 | -0.25 | 0.53 | -312.00% |
| 06/2021 | -0.11 | 0.22 | -300.00% |
| 03/2021 | -0.27 | -0.03 | -88.82% |
| 12/2020 | -0.27 | -0.23 | -13.75% |
| 09/2020 | 0.02 | -0.08 | -544.44% |
| 06/2020 | -0.08 | 0.12 | -256.52% |
| 03/2020 | -0.11 | -0.07 | -37.31% |
| 12/2019 | 0.10 | -0.06 | -158.17% |
Financial Strength
as of 4:00 ET PM 01/13/2022| Pre-Tax Margin | 6.37 |
|---|---|
| Net Margin | 0.00 |
| Operating Margin | 6.85 |
| Return On Equity | 3.07 |
| Return On Assets | 2.35 |
| Inventory Turnover (TTM) | 5.58 |
| Sales Growth (MRQ) | 14.17 |
Ratios
as of 4:00 PM ET 01/13/2022| Price/Earnings (TTM) | 62.81 |
|---|---|
| Price/Book (MRQ) | 1.79 |
| Price/Cash Flow (TTM) | 43.58 |
| Book Value (MRQ) | 17.20 |
| Quick Ratio (MRQ) | 5.07 |
| Current Ratio (MRQ) | 5.60 |
| Total Debt/Equity (MRQ) | 0.07 |
Short Interest
as of 4:00 PM ET 01/14/2022| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:00 ET PM 01/13/2022| Current Qtr (12/2021) |
Next Qtr (03/2022) |
|
|---|---|---|
| Consensus Estimate | $-0.75 | $-0.48 |
| # of Estimates | 5 | 2 |
| High Estimate | $-0.72 | $-0.39 |
| Low Estimate | $-0.79 | $-0.56 |
| Year Ago EPS | $-0.23 | $-0.03 |
| Year Over Year Growth Estimate | 222.00% | 1,339.39% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $-0.03 | $-0.62 |
| # of Estimates | 5 | 5 |
| High Estimate | $0.00 | $0.60 |
| Low Estimate | $-0.06 | $-1.26 |
| Year Ago EPS | $-0.27 | $-0.03 |
| Year Over Year Growth Estimate | -90.37% | 2,276.92% |
| Current Qtr (12/2021) |
Next Qtr (03/2022) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $-0.75 | $-0.48 | $-0.03 | $-0.62 |
| # of Estimates | 5 | 2 | 5 | 5 |
| High Estimate | $-0.72 | $-0.39 | $0.00 | $0.60 |
| Low Estimate | $-0.79 | $-0.56 | $-0.06 | $-1.26 |
| Year Ago EPS | $-0.23 | $-0.03 | $-0.27 | $-0.03 |
| Year Over Year Growth Estimate | 222.00% | 1,339.39% | -90.37% | 2,276.92% |
Insider Information Summary
as of 12/31/1969| % Insiders - 6.41% | |
| % Remaining Total Shares - 93.59% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 104.00 | 13.10 K |
| Shares Bought | 819.00 | 18.29 K |
| Shares Sold | 715.00 | 5.19 K |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
Latest News
Status Quo Great for Stocks: Cramer's 'Mad Money' Recap
May 5, 2019 11:33 AM EDT
International Paper, Inogen, Teva Pharmaceuticals: 'Mad Money' Lightning Round
Aug 16, 2017 6:36 AM EDT
Fantasy Football and Picking Stocks: Cramer's 'Mad Money' Recap
Aug 16, 2017 5:59 AM EDT
Inogen (INGN) Showing Signs Of Being Strong And Under The Radar
Jul 7, 2016 10:15 AM EDT
Today's Weak On High Volume Stock: Inogen (INGN)
May 10, 2016 10:08 AM EDT
3 biotech stocks with charts to watch -- and one bonus stock!
Apr 16, 2016 11:00 AM EDT
4 momentum stocks worth watching right now
Apr 7, 2016 1:09 PM EDT
Insider Trading Alert - INGN, HYGS And DXYN Traded By Insiders
Apr 5, 2016 10:30 AM EDT
Inogen (INGN) Stock Spikes on Q4 Earnings Beat, Guidance
Mar 15, 2016 3:42 PM EDT
Strong On High Volume: Inogen (INGN)
Mar 15, 2016 10:41 AM EDT
5 hated earnings stocks you should love
Mar 14, 2016 10:51 AM EDT
Today's Dead Cat Bounce Stock Is Inogen (INGN)
Nov 20, 2015 10:13 AM EST
Strong On High Relative Volume: Inogen (INGN)
Nov 11, 2015 10:11 AM EST
Insider Trading Alert - IMPR, INGN And APOL Traded By Insiders
Oct 5, 2015 10:30 AM EDT
Inogen (INGN) Reaches New Lifetime High Today
Sep 10, 2015 2:51 PM EDT
Insider Trading Alert - INGN, WTS And RP Traded By Insiders
Sep 4, 2015 11:00 AM EDT
Today Inogen (INGN) Hits New Lifetime High
Sep 3, 2015 10:46 AM EDT
Inogen (INGN) Hits New Lifetime High
Aug 12, 2015 9:45 AM EDT
Strong And Under The Radar: Inogen (INGN)
Aug 10, 2015 9:46 AM EDT
Strong And Under The Radar Today: Inogen (INGN)
Jul 30, 2015 9:46 AM EDT
Trade-Ideas: Inogen (INGN) Is Today's Strong And Under The Radar Stock
Jun 18, 2015 9:54 AM EDT
Inogen (INGN) Highlighted As Strong And Under The Radar Stock Of The Day
Jun 4, 2015 10:21 AM EDT
Inogen (INGN) Showing Signs Of Being Strong And Under The Radar
May 27, 2015 1:10 PM EDT
4 Stocks Breaking Out on Big Volume
Aug 26, 2014 7:00 AM EDT
Recent Articles from TheStreet
Dollar Tree Shoppers Buck at Retailer's Price Hike to $1.25
Consumers take to social media to vent their frustration with Dollar Tree's price plan.
The Arena Group to Buy AMG/Parade as Anchor of New Lifestyle and Entertainment Vertical
Parade Media to Anchor New Lifestyle Vertical; Brings Iconic Title and Premium Content with Significant Local Footprint
Microsoft To Buy 'Call of Duty' Maker Activision Blizzard For $68.7 Billion
Microsoft made its most aggressive play into the video game space Tuesday with a $68.7 billion takeover bid for Call of Duty maker Activision Blizzard.
Stock Market Today - 1/18: Dow Futures Slump As Oil Prices, Treasury Yields Surge; Activision Blizzard Soars
Wall Street looks set for another rough session as a surge in Treasury bond yields, as well as the highest oil prices in seven years, grips global markets.
Goldman Sachs Misses Q4 Earnings Forecast; Investment Banking Fees Surge
Goldman Sachs followed its larger rival, JPMorgan, in booking solid investment banking fees, but missed Street forecasts for its headline Q4 earnings.
U.S. Airlines Warn of 'Catastrophic Disruptions' From 5G Network Rollouts
"The vast majority of the traveling and shipping public will essentially be grounded," unless safety concerns linked to 5G network rollouts are addressed, airline bosses have warned.
5 Steps to Identify Your Target Audience
Identifying your target audience enables you to assess demand and modify to better meet customer needs. Follow these simple steps to identify your target audience.
Oil Hits 7-Year High As Deadly Attack on UAE Depot Sparks Gulf Tensions
A Houthi-lead drone strike on oil facilities in the UAE has global crude prices trading at the highest levels in seven years Tuesday.
Stocks Slump, Earnings In Focus, Airlines and Activision Blizzard - 5 Things You Must Know
Stock Futures Slump As Bond Yields, Oil Prices Leap; Week Ahead: Earnings in Focus After Mixed Q4 Start; Airlines Warn On 5G Disruption After Another Chaotic Weekend For Flights; Activision Blizzard Confirms Firings in Sexual Harassment Probe and GlaxoSmithKline Rejects $68 Billion Unilever Bid For Consumer Goods Division.
Can Netflix Hold off Disney, Amazon, and HBO in the Streaming Wars?
Streaming video giant Netflix has come a long way from its early days of mailing physical copies of DVDs to its customers across the country.